Clinical pharmacology of loop diuretics: a comparative study

Area of Science:

• Pharmacology
• Nephrology
• Internal Medicine

Background:

• Loop diuretics are essential for managing fluid overload.
• Understanding the comparative efficacy of furosemide, bumetanide, and piretanide is crucial for optimizing clinical use.
• Refractory ascites presents a significant therapeutic challenge.

Purpose of the Study:

• To elucidate the characteristics, analogies, and differences among furosemide, bumetanide, and piretanide.
• To establish more precise clinical indications for these loop diuretics.
• To evaluate their efficacy in treating refractory ascites.

Main Methods:

• Comparative analysis of bumetanide and piretanide using compensated diuresis.
• Assessment of the efficacy of furosemide, bumetanide, and piretanide in refractory ascites models.
• Dose-equivalence adjustments for diuretic administration.

Main Results:

• Furosemide, bumetanide, and piretanide demonstrated analogous therapeutic results when administered at equivalent doses.
• Intensive diuresis was identified as the key factor in resolving refractory ascites.
• No significant differences in efficacy were observed between the diuretics at comparable doses.

Conclusions:

• Loop diuretics furosemide, bumetanide, and piretanide exhibit similar efficacy profiles at equivalent doses.
• Effective management of refractory ascites requires an intensive diuresis strategy.
• The findings support refined clinical decision-making regarding loop diuretic selection and dosage.